AlexisCano
Posted - 4 hours ago
$SKYE $ACHV 😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic.
SammyD83
Posted - 2 days ago
$ACHV
MrTicker
Posted - 3 days ago
$ACHV not a major sell off. Slowly being brought down on low volume as I suspect to draw more institutional/private investment interest. JMO
SammyD83
Posted - 3 days ago
$ACHV
Ronald_Lamb
Posted - 3 days ago
$SKYE $ACHV MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏
bobtheknob
Posted - 4 days ago
$ACHV How much capital do you think they will raise? 100 million to fund a p3 vaping trial and get us through FDA approval?
Greyhound14
Posted - 4 days ago
$ACHV First, the bad news. The new CEO, Rick Stewart, the same man who nearly bled the company to death and ran it into the ground prior to Bencich performing CPR, publicly and blatantly lied to all of us when he alluded to a chilled M&A market. That's not a good start. Now, the good news. We can safely presume that the offers received to date were extremely low. Partly due to the lack of patent protection, and partly because that's the nature of first offers. We'll never know the behind-the-scenes dealings but I can say from personal experience that low-balling is just part of the game. We're all guilty of it, too, every time we buy a home or car or any other big-ticket item. The current and past offers are indicative of what the market is willing to pay right now, not what consumers are willing to pay 3 years from now. More good news? Well, there's not been an approved nicotine-free smoking cessation drug approved in 20 years, and there's 50+ years of safety and efficacy data.
InquisitorD
Posted - 4 days ago
$ACHV announces investor conference…. Meetings will be conducted at the Jefferies London Healthcare Conference on November 19-21, 2024, in London, and the Piper Sandler 36th Annual Healthcare Conference on December 3-5, 2024, in New York City.
bobtheknob
Posted - 5 days ago
$ACHV So OL study to conclude late January/early February. That puts NDA submission in May 2025. Since ACHV said it will take 3 months to collect/analyze/incorporate the data. That puts FDA approval at Q3 2026. They plan to share the results of the OL study prior to NDA submission. I think afterward we could get a serious offer from a partner/acquirer. What do you guys think about that potential timing?
Greyhound14
Posted - 5 days ago
$ACHV I like the idea of going at it alone. I know others may disagree but I think it's the only way to unlock the full value of this company. If you think about it, we've got the biggest hurdle --- manufacturing -- out of the way if Sopharma can meet the FDA threshold for quality control. Ordinarily I think building out a sales team would be difficult, but not if Achieve has sufficient cash to poach some of the best Pharma reps from elsewhere. It won't take long for word to spread to doctors about cytisinicline once it's approved. There hasn't been a breakthrough since Chantix and every doctor knows about those side effects. Pre-dilution, this was a $200 stock. Going at it alone is the only way to get back to that target. 40mm TAM (USA); assume 15% market penetration. 6mm x $1500/treatment = $9 billion gross Assume 25% net (or royalty if we partner) and we're at $2.25B. If we go at it alone we'll need to dilute more so let's use 100mm shares. EPS would be $22.5, 15x P/E = $337.50/share.
Jokerjoker
Posted - 1 week ago
$ACHV I know everyone is bummed out about the CC but unicorns and lollipops doesn't always work out just strange how this stuff works out, I own $SOFI and $WMT about six months ago big Saudi investor let go all of his stakes and everyone was in panic and it has been on a run since Walmart sold their stake in $JD and everyone was saying Walmart needs to raise money and was in trouble and three months later it is sitting at ATH. As a result don't always think the ship won't sail I tend to run stocks like a dentist uses Novocaine give it some time and it usually works
Article_AI
Posted - 1 week ago
$ACHV Achieve Life Sciences: Promising Future with Strategic Leadership and Strong Financial Position Justifies Buy Rating Achieve Life Sciences (ACHV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCa... https://www.stck.pro/news/ACHV/92827203/
Greyhound14
Posted - 1 week ago
@DanMarinolong @bobtheknob take a look at $AVXL then, it’s my other big holding besides $ACHV. You may like it, similar story about a massive market and unmet need.
Greyhound14
Posted - 1 week ago
$ACHV Today's 10% drop has little to do with the company. Some retail or funds may be selling because it appears there's a better chance we will not be looking for a partner or a buyout (I think this was a fundamental disagreement between Stewart and Bencich that led to Bencich's dismissal) and it should have been clear that nobody is going to pay top dollar for an asset that lacks basic patent protection -- it's why nobody cared to develop the drug in the US for 50+ years. The best plan is to go at it alone. It's riskier and more expensive up-front, but the rewards are exponentially greater if it pans out. And with an unmet need for smoking cessation, I don't think that it'll take too much convincing for doctors to prescribe cytisinicline when it becomes approves. Also, algorithms saw that we missed earnings estimates by 25% so I suspect that the stock is being heavily shorted. Of course we missed earnings -- we have zero salable products and had to buyout an ex-CEO.
DoofyInvests
Posted - 1 week ago
$ACHV Fun times!
Tamirahard
Posted - 1 week ago
$ACHV back in at 4
Tamirahard
Posted - 1 week ago
$ACHV ouch
Jokerjoker
Posted - 1 week ago
$ACHV yep that's what I heard kinda said the golden age of big pharma BO is over hopefully they planned and no more offerings if so this could turn into another three years hold
bobtheknob
Posted - 1 week ago
$ACHV The sole strategy is no longer Partnership/sale of the company, but to also pursue this on their own. the previous strategy lead to low ball offers/deals.
bobtheknob
Posted - 1 week ago
$ACHV No early data read out. instead the 300 patients won’t complete treatment till January/Febuary. Data is going to be locked and submitted with the NDA. Looks like NDA submission is later in Q2.
bobtheknob
Posted - 1 week ago
$ACHV $1.9 million cost this past quarter for executive restructure and severance comp. John the bandit.
MrTicker
Posted - 1 week ago
$ACHV" As a result of the transactions contemplated by the Debt Agreement, the Registrant is filing this Post-Effective Amendment to deregister any and all securities that remain unsold under the Registration Statement as of the date hereof. In accordance with the undertakings made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any securities that had been registered for issuance but remain unsold at the termination of the offering, the Registrant hereby removes and withdraws from registration any and all securities registered pursuant to the Registration Statement that remain unsold as of the date hereof. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities."
MrTicker
Posted - 1 week ago
$ACHV Form POS AM ACHIEVE LIFE SCIENCES, 10K WIZARD 3:31 PM ET 11/7/2024 http://archive.fast-edgar.com/20241107/AM2ZE223ZM223928222Q2Z42AISCZK22ZD62 Filed on: November 7, 2024
MrTicker
Posted - 1 week ago
$ACHV Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate UpdateCompany to host conference call at 4:30 PM EST today, Thursday, November 7, 2024 GLOBENEWSWIRE 3:05 PM ET 11/7/2024
Kylor
Posted - 1 week ago
$ACHV the change of CEO, will probably bring us some bullish news along with the earnings 🚀🚀🚀
bobtheknob
Posted - 1 week ago
$ACHV Looks like the Trump bump may be short lived. Unless we get material news ACHV will probably continue to trade between $4.50 and $5.50
MrTicker
Posted - 1 week ago
$ACHV https://www.factcheck.org/2024/11/trump-embraces-rfk-jr-s-views-on-vaccines-fluoride/ jump in share price could be due to Trumps win. He's not a smoker, pro approval acceleration as we know vaping is an increasing issue among young adults. RFK jr, a former addict has focused his life to helping people battle addictions of all sorts. MM's could see this as a positive for ACHV! Just my 2 cents.
Jokerjoker
Posted - 1 week ago
$ACHV ok can anyone help me out why the jump? I know my $SOFI would jump with trump coming in because he was going to stop the games with the student loan debt forgiveness Could this be jumping because maybe some of the red tape will be cut?
Monothree88
Posted - 1 week ago
$ACHV what are we expecting for this call on the 7th?
